<Record>
<Term>Second-Generation Antidepressive Agents</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Antidepressive Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Central Nervous System Agents/Psychotropic Drugs/Antidepressive Agents/Antidepressive Agents, Second-Generation</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Psychotropic Drugs</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Antidepressive Agents, Second-Generation</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Antidepressive Agents</BroaderTerm>
<BroaderTerm>Central Nervous System Agents</BroaderTerm>
<Synonym>Second-Generation Antidepressive Drugs</Synonym>
<Synonym>Atypical Antidepressants</Synonym>
<Synonym>Second-Generation Antidepressive Agents</Synonym>
<Synonym>Second Generation Antidepressive Agents</Synonym>
<Description>A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake.</Description>
<Source>MeSH</Source>
</Record>
